Patent · US Active

Activatable recombinant neurotoxins

US7985411B2 · kind B2 · utility

9Cited by

13References

26Claims

0Family size

Assignee

Allergan, Inc. · US

Inventors

J. Oliver Dolly · Cheam, GB
Yan Li · Tallahassee, US
Kuo Chion Chan · London, GB

Key dates

Filing date	Aug 18, 2008
Grant date	Jul 26, 2011
Priority date	—
Expiry date	Feb 12, 2029

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compositions comprising activatable recombinant neurotoxins and polypeptides derived therefrom. The invention also comprises nucleic acids encoding such polypeptides, and methods of making such polypeptides and nucleic acids.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.